share_log

Bristol-Myers Receives FDA Accelerated Approval For Repotrectinib

Benzinga ·  Jun 14 01:14
Bristol-Myers Receives FDA Accelerated Approval For Repotrectinib
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment